Vertigo & Balance

Vertigo & Balance: A Nutritional and Natural-Health Reference

1. Definition and Conceptual Overview

A balance disorder is a disturbance that causes an individual to feel unsteady — for example, when standing or walking. It may be accompanied by feelings of giddiness or wooziness, or a sensation of movement, spinning, or floating. The term vertigo specifically describes a false perception of motion, most commonly a spinning sensation, and is distinguished in the neurological literature from the broader category of dizziness. The term vertigo usually describes a sense of spinning and motion, and differs from the term dizziness (floating sensation) and/or imbalance (loss of balance, unsteadiness), even if in clinical practice all these terms are often used as synonyms.

A balance disorder is a condition that makes you feel unsteady or dizzy, and may be caused by certain conditions, medications, or problems in the ear or brain. There are more than a dozen different balance disorders.

2. Presentation and Symptoms

Symptoms of a balance disorder may include: dizziness or vertigo (a spinning sensation); falling or feeling as if you are going to fall; staggering when trying to walk; lightheadedness, faintness, or a floating sensation; blurred vision; confusion or disorientation. Other symptoms may include nausea and vomiting, diarrhea, changes in heart rate and blood pressure, and fear, anxiety, or panic. Symptoms may come and go over short time periods or last for a long time, and can lead to fatigue and depression.

Symptoms may be constant or come and go, with episodes lasting from minutes to days. Nystagmus — flickering of the eyes related to the vestibulo-ocular reflex — is often seen in patients with an acute peripheral cause of dizziness.

3. Body Systems Involved

Balance is the result of several body systems working together: the visual system (eyes), the vestibular system (ears), and proprioception (the body's sense of where it is in space). Degeneration or loss of function in any of these systems can lead to balance deficits.

The vestibular system is a sensory system responsible for the regulation of balance, oculomotor control, spatial orientation, and perception of self-motion. The vestibular system works in conjunction with vision, the proprioceptive system, and the cerebellum to maintain equilibrium. A loss or mismatch of any of these signals can cause the perception of vertigo.

When you move, the vestibular system detects mechanical forces, including gravity, that stimulate the semicircular canals and the otolithic organs. These organs work with other sensory systems in your body, such as vision and the musculoskeletal sensory system, to control the position of your body at rest or in motion. This helps you maintain stable posture and keep your balance when walking or running, and also helps you keep a stable visual focus on objects when your body changes position.

The balance function is conveyed by three semicircular canals as well as a utricle and saccule. The canals sense rotational movements and the utricle and saccule are responsible for vertical and horizontal movements. The utricle and saccule contain a membrane that holds crystals called otoliths. The movement of these crystals over the membrane allows us to sense movement of the body.

The sense of balance is controlled by signals to the brain about body movement and position in relation to the environment. The brain integrates this information and sends signals back to the muscles on how to maintain balance. If the brain cannot process signals from all of these systems, or if the messages are not functioning properly, a loss of balance may result.

Peripheral vs. Central Vertigo

Vestibular dysfunction is a disturbance in the body's balance system due to an insult to the vestibular system of the inner ear, the central nervous system processing centers, or both. Most cases of vertigo are attributed to peripheral causes that typically present acutely. In contrast, central vertigo is, by definition, caused by pathology originating within the central nervous system.

4. Major Clinical Subtypes

Benign Paroxysmal Positional Vertigo (BPPV)

BPPV is the most common cause of vertigo. It is typically described as a brief, intense sensation of spinning that occurs when there are changes in the position of the head with respect to gravity. An individual may experience BPPV when rolling over to the left or right, upon getting out of bed in the morning, or when looking up for an object on a high shelf. It occurs when particles (otoconia) break loose and fall into the wrong part of the semicircular canals in the inner ear, giving a sensation of spinning (vertigo). The cause of BPPV is not always known, but it may be a result of ageing or head trauma.

Ménière's Disease

In people with Ménière's disease and secondary endolymphatic hydrops, fluid (endolymph) is thought to build up in the inner ear, which can cause numerous symptoms such as pressure or fullness in the ears, tinnitus (ringing in the ears), hearing loss, dizziness, vertigo, and imbalance. There is a strong belief that Ménière's disease involves an excess pressure of the sodium-rich fluid (called endolymph) in the inner ear.

Vestibular Migraine

Vestibular migraine (VM) is the most frequent causal factor in recurring spontaneous vertigo, affecting approximately 1% of people and 10% of those suffering migraines. Females are disproportionately affected by VM at a ratio of 3:1 compared to males.

5. Contributing and Associated Factors

Age and Sex

A systematic review by Murdin and Schilder (2015) identified that the rate of vestibular dysfunction increases with age, and women are more likely to experience dizziness and vertigo symptoms than men. The age-related deterioration of vestibular function seems to be linked to a decreased number of vestibular hair cells and neurons, although alterations affecting the central pathways are also reported.

Cardiovascular and Metabolic Factors

In a systematic literature review of elderly patients with vertigo, the most common origin was audio-vestibular disorders (28.4%), followed by cardiovascular (20.4%) and neurological diseases (15.1%). Approximately 9.1% of patients were diagnosed with psychiatric conditions, while ophthalmologic and musculoskeletal disorders accounted for 7.5% and 6.3% of cases respectively. Medication adverse effects and metabolic-related diseases were also considered among the causes.

Risk factors for BPPV recurrence include advanced age, female sex, hypertension, diabetes mellitus, hyperlipidemia, osteoporosis, and vitamin D deficiency. Risk factors for atherosclerosis, subjective imbalance, and abnormality of optokinetic nystagmus were identified as predictors for balance disorder in patients with dizziness/vertigo who walk independently.

Falls and Quality of Life

When dizziness patients present with balance disorder, it brings many severe morbidities such as falls. Falls have become a troublesome and threatening public health issue, leading to many serious consequences such as fracture, mobility restriction, decreased daily life ability, and mood disorder. Falls can cause life-threatening injuries, especially in the elderly, often leading to hospitalization and nursing home admission, and bringing large medical expenditures. Meanwhile, dizziness and balance disorder also reduce quality of life and bring huge economic burden.

6. Nutrients, Herbs, and Natural Ingredients

6A. Vitamin D

Relationship to BPPV

BPPV is an inner ear disorder characterized by recurrent episodes of positional vertigo. The connection between vitamin D insufficiency/deficiency and the onset and recurrence of BPPV is established. Recent studies have revealed that vitamin D deficiency correlates with BPPV and this is explained by cupulolithiasis and canalithiasis theories. The proposed mechanism is that vitamin D deficiency may impair calcium metabolism in the otolith organs, potentially leading to abnormal otoconia formation or reabsorption.

Scientific Evidence

Low levels of vitamin D have been found in patients with vestibular disorders such as BPPV, Ménière's disease, and vestibular neuritis. A few reports have shown supplementation to be beneficial for preventing BPPV attacks and Ménière's symptoms.

A longitudinal clinical trial (PMC4913711) enrolled BPPV patients with confirmed vitamin D deficiency and assigned them to: (1) rehabilitation alone, (2) rehabilitation plus vitamin D supplementation (50,000 IU cholecalciferol weekly for two months), or (3) a vitamin-D-sufficient control group. After two months of treatment, in both vitamin D treated and non-treated groups the intensity of BPPV decreased significantly, but at endpoint the intensity of BPPV aggravated and regressed to the baseline value in the vitamin D deficient non-treated group, whereas in the vitamin D treated group, improvement remained stable and unchanged over the study period. This study indicates that correction of vitamin D deficiency in BPPV provides additional benefit to rehabilitation therapy (Epley maneuver) regarding duration of improvement, suggesting serum 25-OHD measurement in recurrent BPPV.

One study found that vitamin D levels of individuals in the BPPV group were statistically significantly lower than those in the control group. However, it was observed that vitamin D did not affect the rate of vertigo subtypes.

Earlier studies did not establish a link between low vitamin D levels and initial BPPV occurrence, but they did associate recurrent episodes with low vitamin D levels. Recurrence rates for BPPV varied from 13.7% to 23% for studies with follow-up less than one year, and 13.3% to 65% for studies with follow-up equal to or exceeding two years. Overall, the evidence for vitamin D and BPPV is moderately strong for the association, particularly regarding recurrence, but the evidence base for supplementation outcomes remains limited by small sample sizes and methodological heterogeneity.

6B. Ginkgo Biloba (Ginkgo biloba L.)

Traditional Use

Ginkgo biloba has a history of use in traditional Chinese medicine, where preparations from the leaf and seed have been employed for centuries in the context of respiratory, circulatory, and cognitive complaints. Its use in the modern Western herbal tradition for circulatory insufficiency and associated symptoms such as dizziness and tinnitus derives substantially from standardized German phytomedicine research beginning in the latter half of the 20th century.

Scientific Evidence

Studies have reported that Ginkgo biloba has the effects of antiplatelet aggregation, improved circulation, antioxidation, and blood glucose reduction. Dizziness associated with central neurological disorders is a clinically challenging and heterogeneous condition with limited treatment options. Ginkgo biloba extract — through its microcirculatory, neuroprotective, and anti-inflammatory mechanisms — represents a biologically plausible intervention.

A 2026 systematic review and meta-analysis of nine RCTs published in Frontiers in Neurology evaluated the standardized extract EGb 761 in patients with dizziness or vertigo associated with central neurological disorders. Ginkgo biloba significantly reduced dizziness severity, as measured by the 11-point box scale and the VAS, with moderate to low certainty of evidence. Ginkgo biloba also conferred clinically meaningful and statistically robust improvements in activities of daily living (ADL-IS) and quality of life (DEMQOL-Proxy), supported by moderate-certainty evidence.

A randomized, double-blind controlled trial (PMC12775334) directly compared EGb 761 with betahistine (a conventional vestibular drug) over 12 weeks in 86 patients with dizziness/vertigo of unclear etiology. The results complemented findings from placebo-controlled trials of EGb 761 that demonstrated its clinical efficacy in vestibular and nonvestibular vertigo, with more than 70% of patients rated "much improved" or "very much improved." This is consistent with evidence from a Cochrane systematic review, which reported that most clinical trials demonstrating therapeutic benefit employed daily doses between 24 and 48 mg.

A meta-analysis examining EGb 761 in dementia patients found that EGb 761 was clearly superior to placebo in alleviating both tinnitus and dizziness, in line with results of earlier trials in patients with tinnitus or vertigo, in whom these neurosensory symptoms were the main complaints. Systematic reviews found EGb 761, but not other G. biloba extracts, to be effective in the treatment of tinnitus and vertigo.

Evidence strength: Evidence for the standardized extract EGb 761 in vestibular and dizziness-related applications is moderate; evidence is less consistent for non-standardized ginkgo products. The specificity of effects to the defined standardized extract is an important limitation to generalizing findings.

6C. Ginger (Zingiber officinale Roscoe)

Traditional Use

Since thousands of years ago, ginger has been used as a food and herbal medicine in Asia and the Far East, and its medicinal use is well described in Chinese remedies from 400 BC. The rhizomes have been used since antiquity in various traditional systems of medicine to treat cold, fever, sore throats, infectious diseases, arthritis, rheumatism, sprains, muscular aches, pains, cramps, hypertension, dementia, migraine, nervous diseases, gingivitis, toothache, asthma, stroke, and diabetes, and also as a home remedy for various gastric ailments like constipation, diarrhea, dyspepsia, belching, bloating, gastritis, epigastric discomfort, gastric ulcerations, indigestion, nausea, and vomiting. In Ayurvedic and Chinese medicine, ginger has been administered for motion sickness and nausea associated with movement disorders.

Scientific Evidence

The most active ingredients in ginger are the pungent principles, particularly gingerols and shogaols. Anti-inflammatory, antioxidant, antitumor, and antiulcer effects of ginger have been proven in many scientific studies, and some ancient applications of ginger as a home remedy have been confirmed in humans.

Regarding nausea — a prominent symptom accompanying vertigo — ginger has been studied for several types of nausea and vomiting. Most of the studies tested dietary supplements rather than foods. Research shows that ginger may be helpful for nausea and vomiting associated with pregnancy. Most studies of ginger for motion sickness, however, have not shown it to be helpful. The NCCIH (NIH National Center for Complementary and Integrative Health) notes that it is uncertain whether ginger is a helpful addition to standard treatments for nausea and vomiting associated with cancer chemotherapy, and whether it is helpful for nausea and vomiting after surgery.

Several studies have been performed on the use of ginger as an anti-emetic for use with post-operative nausea and vomiting, motion sickness and vertigo, and chemotherapy-induced nausea and vomiting. A comprehensive systematic review of 109 RCTs found that evidence for improvement of nausea and vomiting in pregnancy was consistently supported, whereas other functions were relatively controversial. Only 43 clinical trials (39.4%) met the criterion of having "high quality of evidence," with small populations and unstandardized evaluation systems as observed shortcomings. Further studies with adequate designs are warranted.

Evidence strength: Evidence for ginger's anti-nausea effects (particularly for pregnancy-related nausea) is reasonably well-supported; its direct effects on vertigo mechanisms themselves remain poorly studied, and evidence for motion sickness specifically is not compelling based on current NCCIH assessment.

6D. Magnesium

Relevance to Vestibular Migraine

Studies have revealed decreased levels of riboflavin, magnesium, and coenzyme Q10 in plasma and in the brain of migraine patients, suggesting a deficit of these nutrients could play a role in the pathophysiology of migraine. Mitochondrial dysfunction is associated with migraine. Riboflavin, magnesium, and coenzyme Q10 play an important role in the production of energy in the mitochondria. Magnesium is needed in various physiological processes influencing the pathophysiology of migraine — including vasoconstriction, platelet inhibition, and secretion of serotonin.

Scientific Evidence

A retrospective cohort study (ScienceDirect, 2024) assessed a combination of magnesium, vitamin B2 (riboflavin), and CoQ10 supplementation in vestibular migraine patients over six months. Frequency of days per month with vestibular migraine decreased from 13.0 to 2.9, a statistically significant reduction (p <0.001). Over 80% of the sample experienced significant decreases in VM attack length (p <0.001). Severity in vestibular migraine, as assessed through the vertigo analogue scale, showed a mean value of 7.2/10 prior to treatment and 2.1/10 following six months' treatment, with good results found for over 71% of the sample (p <0.001). This was a retrospective cohort study without a placebo control arm, which is a significant methodological limitation.

Because high doses are recommended for migraine prevention, a more easily absorbed form like magnesium glycinate may be better tolerated. Different types of magnesium may be recommended for different symptoms.

Evidence strength: Preliminary to moderate for vestibular migraine in combination supplementation studies; the evidence specifically for magnesium alone in vertigo is limited. Large, placebo-controlled RCTs are lacking.

6E. Riboflavin (Vitamin B2)

Relevance to Vestibular Migraine

Riboflavin's role as a mitochondrial cofactor has made it a subject of migraine prophylaxis research, including for vestibular migraine. A 2004 European study found that migraine days were cut in half after three months of daily use of 400 mg B2 riboflavin. The number of migraine-abortive medications was also significantly reduced. Riboflavin was found to be well-tolerated by participants. Natural sources of riboflavin include eggs, lean protein, green vegetables, and fortified cereals and breads.

A case report published in PMC (2019) described a pediatric patient with definite Ménière's disease who became symptom-free and gained near-normal hearing levels after starting on a 6-week migraine diet/lifestyle regimen with riboflavin and magnesium. This is a single case report and cannot be generalized, but adds to the hypothesis of overlap between Ménière's disease and vestibular migraine pathophysiology.

The potential synergy among ingredients like CoQ10, Ginkgolide B, magnesium and feverfew with riboflavin has shown promising results in studies, although the quality of evidence remains low.

Evidence strength: Moderate evidence for riboflavin in migraine prophylaxis broadly; preliminary evidence for vestibular migraine specifically, largely based on small or uncontrolled studies.

6F. Coenzyme Q10 (CoQ10)

Mitochondrial dysfunction is associated with migraine. Riboflavin, magnesium, and coenzyme Q10 play an important role in the production of energy in the mitochondria. Two small but effective studies have shown that CoQ10 may help with migraine prevention. In one study, patients took 150 mg of CoQ10 daily for three months and over half of them experienced a 50% reduction in migraine days without side effects.

Evidence strength: Preliminary; applicable to vestibular migraine by extrapolation from migraine research. Specific vestibular outcomes have not been isolated as primary endpoints in large trials.

6G. Vitamin B12 (Cobalamin)

Relevance to Vestibular Function

Vitamin B12 plays a crucial role in maintaining myelin sheaths protecting nerve fibers involved in balance, and its deficiency can lead to demyelination in the central nervous system and peripheral nervous system. Maintaining adequate cobalamin levels is essential for proper nerve function and the production of red blood cells. Neurological complications, including balance problems, can arise from prolonged deficiency.

Scientific Evidence

The relationship between B12 and vertigo is observed clinically but has a limited evidentiary base in the form of well-controlled trials. One study examined homocysteine, vitamin B12, and folic acid levels of 41 patients with vestibular complaints, and found that homocysteine, vitamin B12, and folic acid levels of patients with Ménière's disease, BPPV, and vestibular neuronitis were in a normal range. This finding — normal B12 in common vestibular disorders — suggests B12 deficiency may be relevant to a subset of patients rather than to vestibular disease in general.

Although vitamin B12 deficiency affected the central nervous system, normal findings were obtained in cervical vestibular-evoked myogenic potential (C-VEMP) testing in one study. In vitamin B12 deficiency, the saccular, inferior vestibular nerve, lateral vestibular nucleus, and medial vestibular pathway appear not to be affected. These objective electrophysiological findings suggest B12 deficiency affects balance through higher CNS pathways rather than peripheral vestibular structures directly.

Evidence strength: Weak and inconsistent for primary vestibular disorders; more relevant when B12 deficiency is documented neurologically. The existing studies are small and often retrospective.

6H. Feverfew (Tanacetum parthenium)

Traditional Use

Feverfew has a long tradition of use in European herbal medicine, particularly in the United Kingdom, for headaches and fever. It was traditionally consumed as fresh leaves incorporated into food or as a tea.

Scientific Evidence

An extremely small study of eight patients showed that headaches were unchanged, yet the frequency of headaches increased significantly when stopping feverfew to switch to placebo. Some studies showed feverfew to be slightly more effective than placebo. Symptoms of nausea and vomiting were also reduced. Other studies have shown it to not be effective for migraine prevention. Other than helping with nausea, there is no clear research on whether this will help vestibular symptoms.

Evidence strength: Weak and mixed for migraine prophylaxis; no established specific evidence for vertigo or vestibular function.

7. Dietary Factors

Sodium (Salt) and Endolymphatic Pressure

People with Ménière's disease should limit their sodium intake because too much sodium can increase fluid in the inner ear. Salt reduction is widely suggested for many people with vertigo, as it is thought to result in a reduction of endolymphatic pressure. Reducing salt intake may help to reduce the frequency and severity of Ménière's attacks.

However, the evidence base for this recommendation is weaker than often assumed. Even though many believe reducing sodium helps with Ménière's disease, a recent review found no proper studies proving this. More research is needed. Research on diet and vestibular disorders is limited, but many people with Ménière's disease, secondary endolymphatic hydrops, and vestibular migraines find that adjusting their diets helps control their symptoms. Controlled studies demonstrating the efficacy of trigger elimination specifically in Ménière's disease are lacking.

Caffeine and Alcohol

Caffeine in excess of one or two cups may worsen symptoms and can be a trigger for some people with vestibular migraine. Caffeine is present in coffee, tea, green tea, energy drinks, and colas, and can also be present in some foods, such as chocolate. Although there aren't many studies on this, caffeine and alcohol might tighten blood vessels, reducing blood flow to the inner ear and worsening symptoms.

Migraine Dietary Triggers

Common migraine food triggers include monosodium glutamate, chocolate, red wine, fermented dairy products including yogurt, and aged or pickled foods. Trigger elimination is advocated as treatment for migraine-associated vestibular disorders, but controlled studies demonstrating the efficacy of this treatment in Ménière's disease are lacking.

Dietary Patterns

A good starting point is to follow national nutrition guidelines, which suggest eating a variety of foods and limiting salt, added sugars, and unhealthy fats. Diets like the Mediterranean diet or DASH diet may also be beneficial. These recommendations for vestibular health are derived by extrapolation from cardiovascular evidence rather than from dedicated vestibular disorder trials.

Research on diet and vestibular disorders is limited, but many people with Ménière's disease, secondary endolymphatic hydrops, and vestibular migraines find that adjusting their diets helps control their symptoms. These adjustments might include changing the types or timing of foods they consume. Anecdotally, people report that reducing caffeine, alcohol, and/or salt has helped them.

8. Lifestyle Factors

Vestibular Rehabilitation Exercise

There is high-level evidence in a Cochrane review that vestibular rehabilitation (VR) is beneficial for treating dizziness caused by a unilateral vestibular problem. VR is safe, effective, and relatively inexpensive in the treatment of unilateral vestibular dysfunction. A multidisciplinary group found strong evidence for the use of VR in the management of unilateral and bilateral vestibular hypofunction.

Prospective controlled studies have provided evidence that vestibular rehabilitation is beneficial in improving postural and gaze stability as well as decreasing subjective complaints for patients with vestibular hypofunction. One study compared a customized 3-month vestibular exercise programme with a generic 3-month exercise programme and found that dizziness decreased by 85% in the vestibular exercise group and 64% in the generic group. Only the vestibular exercise group had a decrease in dizziness with activities of daily living, and had significant improvement in dynamic and static postural control and a reduction in motion sensitivity.

Moderate to strong evidence exists to support vestibular rehabilitation as a safe, effective management for persons with an inner ear balance disorder. However, there is insufficient evidence to discriminate between differing forms of treatment, and although approximately 50% to 80% of persons with a vestibular dysfunction achieve significant symptomatic and objective improvements with regards to their balance, walking, and activities of daily living, some persons do not improve.

Physical Activity and Recovery Factors

Different factors can impact the potential for recovery including activity level, pain, other medical conditions, medications, and emotional concerns. Research shows the brain and inner ears recover best if therapy begins during the first few weeks after a vestibular deficit occurs.

Patients who have a stable vestibular disorder, such as vestibular neuritis or labyrinthitis, have the best opportunity to have a satisfactory resolution of symptoms. When patients have a progressive vestibular disorder, like with multiple sclerosis, or a fluctuating condition, like with migraine and Ménière's disease, which causes spontaneous attacks of dizziness or vertigo, compensation can be difficult to achieve, and therefore, success with VR is more difficult.

Stress and Psychological Factors

Among the most common causes of vertigo in the elderly, three major subgroups are identified: audiovestibular, cardiovascular, and neurological. The possible role of psychiatric disorders has also been highlighted in this age group. Fear, anxiety, or panic are recognized symptoms accompanying vestibular disorders. Symptoms can lead to fatigue and depression.

9. Summary of Evidence Strength

• Vestibular rehabilitation exercise: Strong evidence (Cochrane-level) for unilateral vestibular hypofunction.
• Vitamin D and BPPV recurrence: Moderate evidence from multiple observational studies and clinical trials; association with recurrence is more consistently supported than with initial incidence.
• Ginkgo biloba (EGb 761 standardized extract): Moderate evidence from multiple RCTs and meta-analyses for reducing dizziness severity, particularly in the context of the specific standardized extract. Evidence for non-standardized preparations is weaker.
• Low-sodium diet in Ménière's disease: Widely recommended clinically, but current Cochrane-level reviews identify an absence of controlled trial evidence specifically for this intervention.
• Magnesium + riboflavin + CoQ10 for vestibular migraine: Preliminary to moderate; promising retrospective and small trial data, but lacking large placebo-controlled RCTs specifically for vestibular endpoints.
• Ginger (anti-nausea): Moderate evidence for pregnancy-associated nausea; weak and inconsistent evidence for motion sickness and vestibular-specific nausea.
• Vitamin B12: Weak and inconsistent. Deficiency is associated with neurological symptoms including balance problems, but studies in common vestibular diagnoses (BPPV, Ménière's) have not found consistent deficiency.
• Feverfew: Mixed and weak evidence for migraine; no specific vestibular evidence.
• Caffeine, alcohol, and migraine dietary triggers: Supported primarily by observational and anecdotal data for vestibular conditions; formal controlled evidence is lacking.

References

• PMC10157436 — Vertiginous dizziness: A primary care approach (PMC/NIH)
• National Institute on Deafness and Other Communication Disorders (NIDCD) — Balance Disorders
• American Speech-Language-Hearing Association — Balance System Disorders
• NIH/NCBI StatPearls — Vestibular Dysfunction
• NIH/NCBI StatPearls — Vertigo in Clinical Practice: Evidence-Based Diagnosis and Treatment
• Wikipedia — Balance Disorder (citing referenced literature)
• Johns Hopkins Medicine — Vestibular Balance Disorder
• Better Health Channel (Victoria, Australia) — Dizziness, Vertigo and Balance Disorders
• PMC10058392 — Vertigo in the Elderly: A Systematic Literature Review (PMC/NIH)
• PMC8106193 — Risk Factors Related Balance Disorder for Patients with Dizziness/Vertigo (BMC Neurology, PMC/NIH)
• PMC4913711 — Influence of Supplemental Vitamin D on Intensity of BPPV: A Longitudinal Clinical Study (PMC/NIH)
• PubMed 34413436 — Relation Between Vitamin D Deficiency and Benign Paroxysmal Positional Vertigo
• PMC10934290 — Vitamin D Supplementation and Recurrence of Benign Paroxysmal Positional Vertigo (PMC/NIH)
• PMC11043747 — Association Between Vitamin D Deficiency and BPPV Incidence and Recurrence: A Systematic Review and Meta-Analysis (PMC/NIH)
• PMC10870803 — Vitamin D Deficiency and the Risk of Recurrent BPPV (PMC/NIH)
• PubMed 35747111 — The Relationship Between Benign Paroxysmal Positional Vertigo and Vitamin D
• Frontiers in Neurology — Ginkgo biloba Extract for Dizziness-Related Symptoms in Central Neurological Disorders: A Systematic Review and Meta-Analysis (2026)
• PMC12775334 — Efficacy of EGb 761® and Betahistine in Treatment of Dizziness/Vertigo: A Randomized Double-Blind Controlled Trial (PMC/NIH)
• PMC4099171 — Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing EGb 761 and Betahistine (PMC/NIH)
• PMC6005330 — Ginkgo biloba Extract EGb 761® Alleviates Neurosensory Symptoms in Patients with Dementia: A Meta-Analysis (PMC/NIH)
• NIH/NCBI StatPearls — Ginkgo Biloba
• NIH NCCIH — Ginger: Usefulness and Safety
• PMC7019938 — Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials (PMC/NIH)
• PMC6341159 — Ginger in Gastrointestinal Disorders: A Systematic Review of Clinical Trials (PMC/NIH)
• PMC4818021 — The Effectiveness of Ginger in the Prevention of Nausea and Vomiting during Pregnancy and Chemotherapy (PMC/NIH)
• PMC3995184 — A Systematic Review and Meta-Analysis of the Effect and Safety of Ginger in the Treatment of Pregnancy-Associated Nausea and Vomiting (PMC/NIH)
• ScienceDirect — The Clinical Efficacy and Safety of Ginkgo biloba in Vertigo Patients: A Meta-Analysis (2023)
• ScienceDirect — Effectiveness of Combination Therapy of Magnesium, Vitamin B2 and CoQ10 Supplementation on Vestibular Migraine: A Retrospective Cohort Study (2024)
• PMC4393401 — Improvement of Migraine Symptoms with a Proprietary Supplement Containing Riboflavin, Magnesium and CoQ10: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial (PMC/NIH)
• PMC8041434 — Successful Treatment of a Child with Definite Meniere's Disease with the Migraine Regimen (PMC/NIH)
• PMC4348125 — Optimal Management of Ménière's Disease (PMC/NIH)
• PMC9969956 — Lifestyle and Dietary Interventions for Ménière's Disease (PMC/NIH, Cochrane)
• Vestibular Disorders Association (VeDA) — Natural Supplements for Vestibular Disorders
• Vestibular Disorders Association (VeDA) — Dietary Considerations with SEH, Ménière's Disease & Vestibular Migraine
• Vestibular Disorders Association (VeDA) — Diet Can Reduce Dizziness and Help Manage Vestibular Symptoms
• Vestibular Disorders Association (VeDA) — Vestibular Rehabilitation Therapy (VRT)
• Ménière's & Vestibular UK — Diet and Complementary Therapy
• ScienceDirect — The Role of Vestibular Rehabilitation in the Balance Disorder Patient
• British Society of Audiology — Practice Guidance: Vestibular Rehabilitation (2019)
• Journal of Otolaryngology and Rhinology — Evaluation of Vestibular Evoked Myogenic Potentials Test in Vitamin B12 Deficiency
• SAGE Journals — Vestibular Evoked Myogenic Potentials in Patients With Low Vitamin B12 Levels
• Acta Paediatrica — Systematic Review: Nutraceuticals Containing Vitamin B2 as Alternative Treatment for Paediatric Migraines (2025)